• Home
  • News/Alerts
  • Latest News
  • Survey invitation from the National Allergy Strategy – have your say about accessing allergy care

Survey invitation from the National Allergy Strategy – have your say about accessing allergy care

NAS Shared Care Model SurveyThe National Allergy Strategy is inviting consumer and patient groups affected by allergy to participate in an Australia-wide survey on their experience when accessing health care for their allergic condition(s). 

Anyone with an allergic condition and living in Australia can participate, and we encourage parents and carers of people with allergic conditions to participate also. If you live in a rural or remote part of Australia, we especially would like to hear from you!

The survey takes around 15 minutes to complete and can be accessed via the National Allergy Strategy website.

Your responses will remain anonymous.

You have until Wednesday 20 February 2019 to respond to the survey.

The information you provide will help us understand what is working and what needs to be improved for people accessing health care for allergic conditions.

A survey asking health care professionals about their experiences when providing allergy services is also available via the National Allergy Strategy website.

The National Allergy Strategy is an initiative of the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA), and has received funding from the Australian Government Department of Health to look at better ways to deliver health care to people with allergic conditions.

We encourage you to have your say in this important survey. If you wish to contact us please email This email address is being protected from spambots. You need JavaScript enabled to view it.

Acute Anaphylaxis CSS
Acute Anaphylaxis Clinical Care Standard - Learn more...
Atopic Dermatitis
allergy250K teens/young adults
Food allergy training

Our Supporters

Diamond


Viatris
Sanofi
Nestle
Allergy Concepts

Platinum


  • Bulla
  • NSW Food Authority
  • Novartis
  • Pfizer

Gold


  • dbv technologies
  • Mondelez
  • Nurticia
Silver

  • abbvie
  • Australian Camps Association
  • Bayer
  • Sanctuary Early Learning
  • Sweet William


© 2023 ALLERGY & ANAPHYLAXIS AUSTRALIA
ABN: 70 693 242 620

 



ALLERGY & ANAPHYLAXIS AUSTRALIA
is supported by funding from the
Australian Government,
Department of Health.


ALLERGY & ANAPHYLAXIS AUSTRALIA acknowledges and pays respect to the traditional custodians of the lands on which we work, live and play.

IN AN EMERGENCY

If you are having an allergic reaction follow advice on your ASCIA Action Plan.

If in doubt, give the Anapen® or EpiPen®.

Do not call us for emergency advice.

If you do not have an ASCIA Action Plan and/or an Anapen® or EpiPen® call triple zero (000) for an ambulance.